跳轉至內容
Merck
全部照片(1)

重要文件

PZ0183

Sigma-Aldrich

ERB-041

≥98% (HPLC)

同義詞:

2-(3-氟-4-羟基苯基)-7-乙烯基-1,3-苯并恶唑-5-醇, WAY-202041, 普林贝瑞

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C15H10FNO3
CAS號碼:
分子量::
271.24
MDL號碼:
分類程式碼代碼:
51111800
PubChem物質ID:
NACRES:
NA.77
暫時無法取得訂價和供貨情況

化驗

≥98% (HPLC)

形狀

powder

顏色

white to tan

溶解度

DMSO: ≥25 mg/mL

儲存溫度

room temp

SMILES 字串

OC(C=C1)=C(F)C=C1C2=NC3=CC(O)=CC(C=C)=C3O2

InChI

1S/C15H10FNO3/c1-2-8-5-10(18)7-12-14(8)20-15(17-12)9-3-4-13(19)11(16)6-9/h2-7,18-19H,1H2

InChI 密鑰

MQIMZDXIAHJKQP-UHFFFAOYSA-N

基因資訊

human ... ESR2(2100)

生化/生理作用

ERB-041 是一种强效、选择性 ERβ 受体激动剂(IC50 ERβ:5.4 nM;是 ERα 选择性的 200 倍以上)
ERB-041 是一种强效、选择性雌激素 ERβ 受体激动剂(IC50 ERβ:5.4 nM;选择性是 ERα 的 200 倍以上)。ERβ 在子宫、下丘脑/垂体、骨骼和其他经典雌激素靶组织中介导雌激素作用的作用较小。然而,目前已经确立 ERβ 在卵巢、心血管系统和脑以及炎症动物模型(包括关节炎、子宫内膜异位症、炎症性肠病和败血症)中的明确作用。人们对寻找 ERβ 激动剂越来越感兴趣,其可用于各种临床应用而不会引发经典的雌激素副作用。

特點和優勢

该化合物是受体分类及信号转导手册上核受体(类固醇)页面上的特色化合物。想要浏览手册的其他页面, 请单击此处

象形圖

Exclamation mark

訊號詞

Warning

危險聲明

危險分類

Acute Tox. 4 Oral - Eye Irrit. 2

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Iuliia Savchuk et al.
PloS one, 8(8), e71722-e71722 (2013-08-24)
It is well known that estrogens and estrogen-like endocrine disruptors can suppress steroidogenic gene expression, attenuate androgen production and decrease differentiation of adult Leydig cell lineage. However, there is no information about the possible link between the potency of Leydig
Qian Jiang et al.
Purinergic signalling, 13(1), 105-117 (2016-11-07)
Estrogen receptor beta (ERβ) has been shown to play a therapeutic role in inflammatory bowel disease (IBD). However, the mechanism underlying how ERβ exerts therapeutic effects and its relationship with P2X3 receptors (P2X3R) in rats with inflammation is not known.
Sreenivasan Paruthiyil et al.
PloS one, 4(7), e6271-e6271 (2009-07-18)
Estrogens produce biological effects by interacting with two estrogen receptors, ERalpha and ERbeta. Drugs that selectively target ERalpha or ERbeta might be safer for conditions that have been traditionally treated with non-selective estrogens. Several synthetic and natural ERbeta-selective compounds have
Geriolda Topi et al.
The Journal of pathology, 251(3), 297-309 (2020-04-26)
Oestrogen receptor β (ERβ) has been suggested to have anti-proliferative and anti-tumour effects in breast and prostate cancer cells, but other studies have indicated its tumour-promoting effects. Understanding the complex effects of this receptor in different contexts requires further study.
Ana Paola G Lombardi et al.
Frontiers in endocrinology, 11, 184-184 (2020-04-25)
Prostate cancer is initially dependent on the androgen, gradually evolves into an androgen-independent form of the disease, also known as castration-resistant prostate cancer (CRPC). At this stage, current therapies scantily improve survival of the patient. Androgens and estrogens are involved

文章

我们可提供多种核受体(类固醇)相关产品,满足您的各类研究需求。

We offers many products related to Nuclear Receptors (Steroids) for your research needs.

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務